Your browser doesn't support javascript.
loading
3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).
Cardoso, F; Costa, A; Senkus, E; Aapro, M; André, F; Barrios, C H; Bergh, J; Bhattacharyya, G; Biganzoli, L; Cardoso, M J; Carey, L; Corneliussen-James, D; Curigliano, G; Dieras, V; El Saghir, N; Eniu, A; Fallowfield, L; Fenech, D; Francis, P; Gelmon, K; Gennari, A; Harbeck, N; Hudis, C; Kaufman, B; Krop, I; Mayer, M; Meijer, H; Mertz, S; Ohno, S; Pagani, O; Papadopoulos, E; Peccatori, F; Penault-Llorca, F; Piccart, M J; Pierga, J Y; Rugo, H; Shockney, L; Sledge, G; Swain, S; Thomssen, C; Tutt, A; Vorobiof, D; Xu, B; Norton, L; Winer, E.
Afiliación
  • Cardoso F; European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal.
  • Costa A; European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland.
  • Senkus E; Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
  • Aapro M; Breast Center, Genolier Cancer Center, Genolier, Switzerland.
  • André F; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.
  • Barrios CH; Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil.
  • Bergh J; Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden.
  • Bhattacharyya G; Department of Medical Oncology, Fortis Hospital, Kolkata, India.
  • Biganzoli L; Medical Oncology Department, Hospital of Prato, Prato, Italy.
  • Cardoso MJ; Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal.
  • Carey L; Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center.
  • Corneliussen-James D; METAvivor Research and Support, Annapolis, USA.
  • Curigliano G; Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy.
  • Dieras V; Department of Medical Oncology, Institut Curie, Paris, France.
  • El Saghir N; NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon.
  • Eniu A; Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania.
  • Fallowfield L; Brighton & Sussex Medical School, University of Sussex, Falmer, UK.
  • Fenech D; Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta.
  • Francis P; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Gelmon K; BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada.
  • Gennari A; Department of Medical Oncology, Galliera Hospital, Genoa, Italy.
  • Harbeck N; Brustzentrum der Universitat München, Munich, Germany.
  • Hudis C; Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA.
  • Kaufman B; Sheba Medical Center, Tel Hashomer, Israel.
  • Krop I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston.
  • Mayer M; Advanced Breast Cancer.org, New York, USA.
  • Meijer H; Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands.
  • Mertz S; Metastatic Breast Cancer Network US, Inversness, USA.
  • Ohno S; Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan.
  • Pagani O; Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland.
  • Papadopoulos E; Europa Donna, Nicosia, Cyprus.
  • Peccatori F; European School of Oncology, Milan, Italy and Bellinzona, Switzerland.
  • Penault-Llorca F; Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France.
  • Piccart MJ; Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Pierga JY; Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France.
  • Rugo H; Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco.
  • Shockney L; Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore.
  • Sledge G; Indiana University Medical CTR, Indianapolis.
  • Swain S; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA.
  • Thomssen C; Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany.
  • Tutt A; Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK.
  • Vorobiof D; Sandton Oncology Centre, Johannesburg, South Africa.
  • Xu B; Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Norton L; Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York.
  • Winer E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
Ann Oncol ; 28(1): 16-33, 2017 01 01.
Article en En | MEDLINE | ID: mdl-28177437
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Masculina Tipo de estudio: Clinical_trials / Guideline / Observational_studies Límite: Female / Humans / Male Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Portugal
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Masculina Tipo de estudio: Clinical_trials / Guideline / Observational_studies Límite: Female / Humans / Male Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Portugal